Patent · US Expired

Anti-tumor antibody compositions and methods of use

US7435416B2 · kind B2 · utility

18Cited by
7References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2004
Grant dateOct 14, 2008
Priority date
Expiry dateMay 26, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides antibodies targeted at a tumor antigen prevalent on prostate tumors and methods useful in alleviating cancers expressing the antigen, as well as nucleic acids and cells for expressing the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.